Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center
1. Acquisition of informed concent form
2. Data acquisition from medical record including
- demographic / disease-associated factors
- details of treatment, and its results
- complications during treatment
- genetic data
- survival outcome (upto 10 years)
3. Accumulation of data for 30 years
4. Use of data for other retrospective analysis (including Asan Medical center Cell
Banking basic data)
Observational [Patient Registry]
Observational Model: Cohort, Time Perspective: Prospective
Overall survival
10 year
No
Dae-Young Kim, MD
Principal Investigator
Assistant Professor
South Korea: Institutional Review Board
AMC-HEMREG-ALL
NCT01761682
January 2013
December 2047
Name | Location |
---|